Recombinant DNA Technology-North America Market Status and Trend Report 2013-2023

Date: May 21, 2018
Pages: 151
Price:
US$ 3,480.00
Publisher: MIReports Co., Limited
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: R6668AD5C998EN
Leaflet:

Download PDF Leaflet

Recombinant DNA Technology-North America Market Status and Trend Report 2013-2023
Report Summary

Recombinant DNA Technology-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Recombinant DNA Technology industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole North America and Regional Market Size of Recombinant DNA Technology 2013-2017, and development forecast 2018-2023
Main market players of Recombinant DNA Technology in North America, with company and product introduction, position in the Recombinant DNA Technology market
Market status and development trend of Recombinant DNA Technology by types and applications
Cost and profit status of Recombinant DNA Technology, and marketing status
Market growth drivers and challenges

The report segments the North America Recombinant DNA Technology market as:

North America Recombinant DNA Technology Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico

North America Recombinant DNA Technology Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
by Product
by Types

North America Recombinant DNA Technology Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Biotechnology and Pharmaceutical Companies
Academic & Government Research Institutes
Others

North America Recombinant DNA Technology Market: Players Segment Analysis (Company and Product introduction, Recombinant DNA Technology Sales Volume, Revenue, Price and Gross Margin):
Monsanto Company
Roche
Biogen
Amgen
Novartis
Eli Lilly and Company
GenScript
Pfizer Inc.
Novo Nordisk
Sanofi
Merck KGaA
Profacgen
Biocon
GlaxoSmithKline
Cibus
Horizon Discovery Group
New England Biolabs

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF RECOMBINANT DNA TECHNOLOGY

1.1 Definition of Recombinant DNA Technology in This Report
1.2 Commercial Types of Recombinant DNA Technology
  1.2.1 by Product
  1.2.2 by Types
1.3 Downstream Application of Recombinant DNA Technology
  1.3.1 Biotechnology and Pharmaceutical Companies
  1.3.2 Academic & Government Research Institutes
  1.3.3 Others
1.4 Development History of Recombinant DNA Technology
1.5 Market Status and Trend of Recombinant DNA Technology 2013-2023
  1.5.1 South America Recombinant DNA Technology Market Status and Trend 2013-2023
  1.5.2 Regional Recombinant DNA Technology Market Status and Trend 2013-2023

CHAPTER 2 SOUTH AMERICA MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Recombinant DNA Technology in South America 2013-2017
2.2 Consumption Market of Recombinant DNA Technology in South America by Regions
  2.2.1 Consumption Volume of Recombinant DNA Technology in South America by Regions
  2.2.2 Revenue of Recombinant DNA Technology in South America by Regions
2.3 Market Analysis of Recombinant DNA Technology in South America by Regions
  2.3.1 Market Analysis of Recombinant DNA Technology in Brazil 2013-2017
  2.3.2 Market Analysis of Recombinant DNA Technology in Argentina 2013-2017
  2.3.3 Market Analysis of Recombinant DNA Technology in Venezuela 2013-2017
  2.3.4 Market Analysis of Recombinant DNA Technology in Colombia 2013-2017
  2.3.5 Market Analysis of Recombinant DNA Technology in Others 2013-2017
2.4 Market Development Forecast of Recombinant DNA Technology in South America 2018-2023
  2.4.1 Market Development Forecast of Recombinant DNA Technology in South America 2018-2023
  2.4.2 Market Development Forecast of Recombinant DNA Technology by Regions 2018-2023

CHAPTER 3 SOUTH AMERICA MARKET STATUS AND FORECAST BY TYPES

3.1 Whole South America Market Status by Types
  3.1.1 Consumption Volume of Recombinant DNA Technology in South America by Types
  3.1.2 Revenue of Recombinant DNA Technology in South America by Types
3.2 South America Market Status by Types in Major Countries
  3.2.1 Market Status by Types in Brazil
  3.2.2 Market Status by Types in Argentina
  3.2.3 Market Status by Types in Venezuela
  3.2.4 Market Status by Types in Colombia
  3.2.5 Market Status by Types in Others
3.3 Market Forecast of Recombinant DNA Technology in South America by Types

CHAPTER 4 SOUTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Recombinant DNA Technology in South America by Downstream Industry
4.2 Demand Volume of Recombinant DNA Technology by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Recombinant DNA Technology by Downstream Industry in Brazil
  4.2.2 Demand Volume of Recombinant DNA Technology by Downstream Industry in Argentina
  4.2.3 Demand Volume of Recombinant DNA Technology by Downstream Industry in Venezuela
  4.2.4 Demand Volume of Recombinant DNA Technology by Downstream Industry in Colombia
  4.2.5 Demand Volume of Recombinant DNA Technology by Downstream Industry in Others
4.3 Market Forecast of Recombinant DNA Technology in South America by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF RECOMBINANT DNA TECHNOLOGY

5.1 South America Economy Situation and Trend Overview
5.2 Recombinant DNA Technology Downstream Industry Situation and Trend Overview

CHAPTER 6 RECOMBINANT DNA TECHNOLOGY MARKET COMPETITION STATUS BY MAJOR PLAYERS IN SOUTH AMERICA

6.1 Sales Volume of Recombinant DNA Technology in South America by Major Players
6.2 Revenue of Recombinant DNA Technology in South America by Major Players
6.3 Basic Information of Recombinant DNA Technology by Major Players
  6.3.1 Headquarters Location and Established Time of Recombinant DNA Technology Major Players
  6.3.2 Employees and Revenue Level of Recombinant DNA Technology Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 RECOMBINANT DNA TECHNOLOGY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Monsanto Company
  7.1.1 Company profile
  7.1.2 Representative Recombinant DNA Technology Product
  7.1.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Monsanto Company
7.2 Roche
  7.2.1 Company profile
  7.2.2 Representative Recombinant DNA Technology Product
  7.2.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Roche
7.3 Biogen
  7.3.1 Company profile
  7.3.2 Representative Recombinant DNA Technology Product
  7.3.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Biogen
7.4 Amgen
  7.4.1 Company profile
  7.4.2 Representative Recombinant DNA Technology Product
  7.4.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Amgen
7.5 Novartis
  7.5.1 Company profile
  7.5.2 Representative Recombinant DNA Technology Product
  7.5.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Novartis
7.6 Eli Lilly and Company
  7.6.1 Company profile
  7.6.2 Representative Recombinant DNA Technology Product
  7.6.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Eli Lilly and Company
7.7 GenScript
  7.7.1 Company profile
  7.7.2 Representative Recombinant DNA Technology Product
  7.7.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of GenScript
7.8 Pfizer Inc.
  7.8.1 Company profile
  7.8.2 Representative Recombinant DNA Technology Product
  7.8.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Pfizer Inc.
7.9 Novo Nordisk
  7.9.1 Company profile
  7.9.2 Representative Recombinant DNA Technology Product
  7.9.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Novo Nordisk
7.10 Sanofi
  7.10.1 Company profile
  7.10.2 Representative Recombinant DNA Technology Product
  7.10.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Sanofi
7.11 Merck KGaA
  7.11.1 Company profile
  7.11.2 Representative Recombinant DNA Technology Product
  7.11.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Merck KGaA
7.12 Profacgen
  7.12.1 Company profile
  7.12.2 Representative Recombinant DNA Technology Product
  7.12.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Profacgen
7.13 Biocon
  7.13.1 Company profile
  7.13.2 Representative Recombinant DNA Technology Product
  7.13.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Biocon
7.14 GlaxoSmithKline
  7.14.1 Company profile
  7.14.2 Representative Recombinant DNA Technology Product
  7.14.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of GlaxoSmithKline
7.15 Cibus
  7.15.1 Company profile
  7.15.2 Representative Recombinant DNA Technology Product
  7.15.3 Recombinant DNA Technology Sales, Revenue, Price and Gross Margin of Cibus
7.16 Horizon Discovery Group
7.17 New England Biolabs

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF RECOMBINANT DNA TECHNOLOGY

8.1 Industry Chain of Recombinant DNA Technology
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF RECOMBINANT DNA TECHNOLOGY

9.1 Cost Structure Analysis of Recombinant DNA Technology
9.2 Raw Materials Cost Analysis of Recombinant DNA Technology
9.3 Labor Cost Analysis of Recombinant DNA Technology
9.4 Manufacturing Expenses Analysis of Recombinant DNA Technology

CHAPTER 10 MARKETING STATUS ANALYSIS OF RECOMBINANT DNA TECHNOLOGY

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference
Skip to top


Ask Your Question

Recombinant DNA Technology-North America Market Status and Trend Report 2013-2023
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: